top of page
2022 Rome Action Plan on Paediatric HIV & TB
HIV MEDICINES DURING PREGNANCY AND BREASTFEEDING
Micro Labs commits to:
392. Finalize the development 3-medicine paediatric fixed-dose combination product (RHZ) for treatment of drug-sensitive TB, with an aim of submitting dossier to WHO PQ by Q3 of 2023.
bottom of page